Seyma Bahdoudi
Rouen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cytoprotective and Neurotrophic Effects of Octadecaneuropeptide (ODN) in in vitro and in vivo Models of Neurodegenerative Diseases.
Journal: Frontiers in endocrinology
Published: May 26, 2020
Neuroprotection with the Endozepine Octadecaneuropeptide, ODN.
Journal: Current pharmaceutical design
Published: September 26, 2018
Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes.
Journal: Journal of molecular neuroscience : MN
Published: July 25, 2018
Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.
Journal: Cellular and molecular life sciences : CMLS
Published: July 07, 2017
Endogenous Expression of ODN-Related Peptides in Astrocytes Contributes to Cell Protection Against Oxidative Stress: Astrocyte-Neuron Crosstalk Relevance for Neuronal Survival.
Journal: Molecular neurobiology
Published: February 10, 2017
Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes.
Journal: Journal of neurochemistry
Published: September 29, 2015
The stimulatory effect of the octadecaneuropeptide ODN on astroglial antioxidant enzyme systems is mediated through a GPCR.
Journal: Frontiers in endocrinology
Published: September 05, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026